Telecardiology in the monitoring after percutaneous alcohol septal ablation of obstructive hypertrophic cardiomyopathy

被引：0
|
作者：
Moltrasio, M [1 ]
Cozzi, S [1 ]
Berna, G [1 ]
Galli, S [1 ]
Doria, E [1 ]
Polvani, GL [1 ]
Famoso, G [1 ]
Borghini, E [1 ]
Fassini, G [1 ]
Bartorelli, AL [1 ]
机构：
[1] Univ Milan, Inst Cardiol, IRCCS, Ctr Cardiol Monzino, Milan, Italy
来源：
HEART DISEASE: NEW TRENDS IN RESEARCH, DIAGNOSIS AND TREATMENT | 2001年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Percutancous transluminal septal myocardial ablation (PTSMA) is an alternative therapeutical procedure for patients with severe hypertrophic cardiomiopathy. Alcohol injection may cause arrhythmias and conduction disturbances, even several days after the procedure; this suggests prolonged hospital monitoring. Aim of our study was to evaluate feasibility and usefulness of "telecardiology" after PTSMA for a reduction of hospital stay and a safer hospital discharge.
引用
收藏
页码：479 / 482
页数：4
相关论文
共 50 条
  • [41] Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy A Word of Endorsement
    Liebregts, Max
    Vriesendorp, Pieter A.
    ten Berg, Jurrien M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (04) : 481 - 488
  • [42] Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy A Word of Balance
    Sorajja, Paul
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (04) : 489 - 494
  • [43] Comparison of Alcohol Septal Ablation With Mavacamten in Obstructive Hypertrophic Cardiomyopathy
    Samhan, Ashraf
    Saleh, Danish
    Kim, Ellis Y.
    Hu, Mo
    Mueller, Kayla
    Garza, Abigail
    Schormann, Elizabeth
    Bindra, Parmeen
    Cheema, Baljash
    Fullenkamp, Dominic E.
    Baldridge, Abigail S.
    Puthumana, Jyothy J.
    Flaherty, James D.
    Choudhury, Lubna
    AMERICAN JOURNAL OF CARDIOLOGY, 2025, 239 : 51 - 56
  • [44] Pathological effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy
    Baggish, A. L.
    Smith, R. N.
    Palacios, I.
    Vlahakes, G. J.
    Yoerger, D. M.
    Picard, M. H.
    Lowry, P. A.
    Jang, I-K
    Fifer, M. A.
    HEART, 2006, 92 (12) : 1773 - 1778
  • [45] Alcohol septal ablation in hypertrophic obstructive cardiomyopathy - The need for a registry
    Spencer, WH
    Roberts, R
    CIRCULATION, 2000, 102 (06) : 600 - 601
  • [46] Alcohol Septal Ablation: An Option on the Rise in Hypertrophic Obstructive Cardiomyopathy
    Arevalos, Victor
    Rodriguez-Arias, Juan Jose
    Brugaletta, Salvatore
    Micari, Antonio
    Costa, Francesco
    Freixa, Xavier
    Masotti, Monica
    Sabate, Manel
    Regueiro, Ander
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (11)
  • [47] Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy
    Maron, BJ
    LANCET, 2000, 355 (9202): : 425 - 426
  • [48] Long-term outcome after percutaneous septal ablation for hypertrophic obstructive cardiomyopathy
    Welge, D
    Faber, L
    Krater, L
    Seggewiss, H
    Gleichmann, U
    Horstkotte, D
    EUROPEAN HEART JOURNAL, 2002, 23 : 733 - 733
  • [49] Long-term outcome after percutaneous septal ablation for hypertrophic obstructive cardiomyopathy
    Welge, D
    Faber, L
    Werlemann, BC
    Krater, L
    Seggewiss, H
    Gleichmann, U
    Horstkotte, D
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 173A - 173A
  • [50] Continuous clinical and hemodynamic improvement after percutaneous septal ablation for hypertrophic obstructive cardiomyopathy
    Faber, L
    Krater, L
    Meissner, A
    Ziemssen, P
    Seggewiss, H
    CIRCULATION, 2000, 102 (18) : 420 - 421
12345